NHS Genomic Medicine Service - Most Suitable Provider Process
This is a notice of intention to make an award in respect of the NHS Genomic Medicine Service pursuant to the Most Suitable Provider (MSP) Process for the NHS Genomic Medicine Service (NHS GMS). For the avoidance of doubt, this is an intention to award notice. A notice of the confirmation of the award of each contract will be issued once they are signed.<br/><br/>Pursuant to the NHS GMS contracts, provider are to provide the following functions: <br/>• Organisational leadership, governance and partnership arrangeme...
Buyer
NHS England
Value
£3,850,000,000
Published
23 Oct 2025
Closes
23 Oct 2025
Procurement details
Source
Find a Tender
Region
London
Procurement method
Limited
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
85100000
Health services
Lots
Lot 1 Lot 1 – NHS North-West GMS
£5,175,000,000
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disea...
Delivery: North West (England)
Lot 2 Lot 2 – NHS North-East and Yorkshire GMS
£5,175,000,000
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disea...
Delivery: North East (England)
Lot 3 Lot 3 – NHS Central and South GMS
£5,175,000,000
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disea...
Delivery: East Midlands (England), West Midlands (England)
Lot 4 Lot 4 – NHS East GMS
£5,175,000,000
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disea...
Delivery: East Of England
Lot 5 Lot 5 – NHS South-West GMS
£5,175,000,000
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disea...
Delivery: South West (England)
Lot 6 Lot 6 – NHS North Thames GMS
£5,175,000,000
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disea...
Delivery: London
Lot 7 Lot 7 – NHS South-East GMS
£5,175,000,000
Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disea...
Delivery: South East (England)
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.